1. Home
  2. UDMY vs OPK Comparison

UDMY vs OPK Comparison

Compare UDMY & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Udemy Inc.

UDMY

Udemy Inc.

HOLD

Current Price

$5.95

Market Cap

1.0B

Sector

Real Estate

ML Signal

HOLD

Logo OPKO Health Inc.

OPK

OPKO Health Inc.

HOLD

Current Price

$1.29

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UDMY
OPK
Founded
2009
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
UDMY
OPK
Price
$5.95
$1.29
Analyst Decision
Buy
Buy
Analyst Count
9
5
Target Price
$9.00
$2.28
AVG Volume (30 Days)
4.0M
3.2M
Earning Date
02-12-2026
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$795,801,000.00
$642,067,000.00
Revenue This Year
$2.34
N/A
Revenue Next Year
$2.66
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.53
N/A
52 Week Low
$4.86
$1.11
52 Week High
$10.61
$2.04

Technical Indicators

Market Signals
Indicator
UDMY
OPK
Relative Strength Index (RSI) 58.46 39.62
Support Level $5.77 $1.29
Resistance Level $7.16 $1.37
Average True Range (ATR) 0.33 0.05
MACD 0.08 -0.00
Stochastic Oscillator 38.00 10.06

Price Performance

Historical Comparison
UDMY
OPK

About UDMY Udemy Inc.

Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The company operates under two operating and reportable segments Consumer and Enterprise, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

Share on Social Networks: